Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE) Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007
Internal validation of a model to predict the risk of short-term (10 days) adverse outcomes in patients with pulmonary embolism (PE) Source: Annual Congress 2006 - Pulmonary embolism Year: 2006
Associations of probability scores in pulmonary embolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Feasibility of pretest probability scoring to predict pulmonary embolism (PE) in routine clinical practice Source: Eur Respir J 2003; 22: Suppl. 45, 219s Year: 2003
Inter-observer correlation in detection of pulmonary hypertension (PH) after an acute pulmonary embolism (PE) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019
Diagnostic strategy for pulmonary embolism (PE) Source: Eur Respir J 2004; 24: Suppl. 48, 274s Year: 2004
Correlation study between three different methods that estimate right ventricular function after an acute pulmonary embolism (PE) Source: International Congress 2016 – Acute pulmonary embolism Year: 2016
Influence of clinical characteristics of pulmonary embolism (PE) patients on helical CT performance Source: Eur Respir J 2005; 26: Suppl. 49, 312s Year: 2005
PaO2 /FiO2 ratio in pulmonary embolism; does it help in assessing pretest probability? Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007
Comparison of the clinical probability scores and diagnostic tests of deep venous thrombosis and pulmonary embolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Original, simplified, and modified pulmonary embolism severity indices in risk stratification of pulmonary embolism Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Can D-dimer assay, together with clinical probability predict computed tomography pulmonary angiogram (CTPA) outcomes for pulmonary embolism (PE)? Source: Annual Congress 2011 - Vascular and parenchymal imaging Year: 2011
The potential benefits of outpatient investigations of suspected pulmonary embolism (PE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
A structured clinical model for predicting the probability of pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004
1 year clinical follow-up of patients affected by acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003
Results of dynamic follow-up of patients after idiopathic pulmonary embolism (PE) Source: Eur Respir J 2006; 28: Suppl. 50, 47s Year: 2006
The persistence gammagraphic perfusion defects after an acute pulmonary embolism (PE) is not associated with altered echocardiographic parameters of vascular resistance Source: International Congress 2017 – Pulmonary embolism Year: 2017
Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006
The use test valsalva manoevre (VM) in diagnosis pulmonary hypertension (PH) for early rehabilitation of patients with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 72s Year: 2006